IP Library › Granted Patent US 7,981,419
Granted Patent B2
US 7,981,419 · App. 12/325,551 · Granted Jul 19, 2011

Method for treating hypophosphatemic bone diseases using FGF-23 antibody

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,981,419
App. No.
12/325,551
Granted
Jul 19, 2011
Kind
B2
Abstract

A method for treating a hypophosphatemic bone disease, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition, which contains an antibody that binds to an FGF-23 polypeptide and a pharmaceutically acceptable carrier.

Claims (3)

1. A method for treating X-linked hypophosphatemia (XLH), comprising the step of administering to a subject a pharmaceutical composition comprising:

(i) an antibody that binds to a polypeptide having the amino acid sequence of SEQ ID NO: 2 or 4; and

(ii) a pharmaceutically acceptable carrier.

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2009
From: YAMASHITA, TAKEYOSHI; SHIMADA, TAKASHI; MIZUTANI, SATORU; FUKUMOTO, SEIJI
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 022721/0197 →